Showing 1 - 3 results of 3 for search 'María-Antonia Sepulveda', query time: 0.03s
Refine Results
-
1
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic by Luis Buzón, Carlos Dueñas, Roberto Pedrero, Jose Antonio Iribarren, Ignacio de los Santos, Alberto Díaz de Santiago, Miguel Ángel Morán, Guillermo Pousada, Estela Moreno, Eva Ferreira, Alicia Iglesias, Cristina Martín, Julia Gómez, Laura Rodríguez, Miguel Egido, María-Antonia Sepulveda, Jesús Troya
Published 2023-01-01
Article -
2
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study. by Jesús Troya, Rocio Montejano, Pablo Ryan, Cristina Gómez, Mariano Matarranz, Alfonso Cabello, Francisco Vera, María Antonia Sepúlveda, Ignacio Santos, Gloria Samperiz, Pablo Bachiller, Vicente Boix, Pilar Barrufet, Miguel Cervero, José Sanz, Javier Solís, María Yllescas, Eulalia Valencia, GESIDA-8715 Study Group
Published 2018-01-01
Article -
3
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort by Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Josefa Muñoz, Pepa Galindo, MaríaDolores Merino, Belén de la Fuente, María Antonia Sepúlveda, Pere Domingo, Josefina García, Manuel Castaño, Esteve Ribera, Paloma Geijo, Alberto Romero, Joaquim Peraire, Elisabeth Deig, Bernardino Roca, Elisa Martínez, Vicente Estrada, Marta Montero, Juan Berenguer, Nuria Espinosa
Published 2021-09-01
Article